X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13388) 13388
Book Review (2041) 2041
Publication (672) 672
Newsletter (629) 629
Conference Proceeding (176) 176
Book Chapter (92) 92
Newspaper Article (56) 56
Magazine Article (43) 43
Dissertation (26) 26
Trade Publication Article (16) 16
Web Resource (9) 9
Paper (5) 5
Transcript (3) 3
Book / eBook (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
clopidogrel (12641) 12641
index medicus (8485) 8485
humans (7693) 7693
aspirin (4851) 4851
male (4525) 4525
female (4096) 4096
cardiac & cardiovascular systems (4008) 4008
ticlopidine - analogs & derivatives (3955) 3955
middle aged (3368) 3368
aged (3287) 3287
platelet aggregation inhibitors - therapeutic use (3097) 3097
percutaneous coronary intervention (2565) 2565
treatment outcome (2162) 2162
ticlopidine - therapeutic use (2126) 2126
risk factors (2049) 2049
peripheral vascular disease (1972) 1972
acute coronary syndromes (1970) 1970
antiplatelet therapy (1910) 1910
pharmacology & pharmacy (1718) 1718
platelet aggregation inhibitors - administration & dosage (1712) 1712
prasugrel (1710) 1710
platelet aggregation inhibitors - adverse effects (1667) 1667
ticagrelor (1652) 1652
abridged index medicus (1620) 1620
myocardial-infarction (1566) 1566
hematology (1540) 1540
thrombosis (1525) 1525
stroke (1506) 1506
risk (1431) 1431
drug therapy, combination (1364) 1364
coronary heart disease (1353) 1353
aspirin - therapeutic use (1341) 1341
care and treatment (1340) 1340
therapy (1327) 1327
ticlopidine - administration & dosage (1303) 1303
drug therapy (1247) 1247
acute coronary syndrome (1207) 1207
research (1188) 1188
stents (1188) 1188
platelet aggregation - drug effects (1155) 1155
cardiology (1144) 1144
cardiac patients (1139) 1139
prevention (1122) 1122
ticlopidine - adverse effects (1117) 1117
mortality (1110) 1110
intervention (1109) 1109
adult (1075) 1075
platelet aggregation inhibitors - pharmacology (1053) 1053
medicine, general & internal (1050) 1050
trial (1043) 1043
time factors (1041) 1041
heart attacks (1035) 1035
analysis (1034) 1034
blood platelets (1028) 1028
cardiovascular (1020) 1020
aggregation (942) 942
myocardial infarction (917) 917
prospective studies (916) 916
aged, 80 and over (908) 908
dosage and administration (894) 894
blood platelets - drug effects (889) 889
platelets (876) 876
surgery (873) 873
cardiovascular diseases (871) 871
cardiovascular disease (863) 863
outcomes (849) 849
acute coronary syndrome - drug therapy (824) 824
aspirin - administration & dosage (823) 823
acute myocardial-infarction (811) 811
medical research (803) 803
inhibition (792) 792
patients (781) 781
transluminal angioplasty (772) 772
ticlopidine - pharmacology (754) 754
anticoagulants (749) 749
retrospective studies (745) 745
platelet reactivity (743) 743
medicine & public health (737) 737
bleeding (729) 729
hemorrhage - chemically induced (729) 729
stent thrombosis (722) 722
medicine, experimental (715) 715
artery-disease (714) 714
management (695) 695
angioplasty (690) 690
health aspects (687) 687
dual antiplatelet therapy (679) 679
risk assessment (677) 677
drug-eluting stents (673) 673
stent (673) 673
follow-up studies (656) 656
platelet function tests (655) 655
ticlopidine (655) 655
events (654) 654
warfarin (648) 648
metaanalysis (644) 644
platelet aggregation (629) 629
aspirin - adverse effects (627) 627
st-segment elevation (621) 621
clinical trials (612) 612
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13412) 13412
German (244) 244
Spanish (165) 165
French (142) 142
Russian (126) 126
Polish (62) 62
Korean (39) 39
Chinese (34) 34
Japanese (34) 34
Italian (24) 24
Czech (21) 21
Turkish (19) 19
Portuguese (18) 18
Croatian (6) 6
Dutch (3) 3
Persian (3) 3
Slovak (3) 3
Hungarian (2) 2
Lithuanian (2) 2
Malay (2) 2
Romanian (2) 2
Serbian (2) 2
Swedish (2) 2
Belarusian (1) 1
Greek (1) 1
Norwegian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2013, Pharmacology-research, safety testing, and regulation series, ISBN 1629483362
Web Resource
Revista española de cardiología, ISSN 0300-8932, 2011, Volume 11, Issue 1, pp. 14 - 19
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 03/2018, Volume 46, Issue 3, pp. 291 - 291
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 02/2018, Volume 103, Issue 2, pp. 217 - 223
Only limited data are available regarding the treatment of critically ill patients with clopidogrel. This trial investigated the effects and the drug... 
PHARMACODYNAMIC RESPONSES | POLYMORPHISMS | PHARMACOKINETICS | HIGH-DOSE CLOPIDOGREL | ACUTE MYOCARDIAL-INFARCTION | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | TREATMENT PLATELET REACTIVITY | PRASUGREL | CYP2C19 | CORONARY-ARTERY-DISEASE | Activation, Metabolic | Clopidogrel - blood | Humans | Middle Aged | Critical Illness | Half-Life | Male | Microfilament Proteins - blood | Clopidogrel - administration & dosage | Drug Monitoring - methods | Clopidogrel - pharmacokinetics | Pantoprazole - administration & dosage | Platelet Aggregation Inhibitors - blood | Austria | Pantoprazole - pharmacokinetics | Phosphoproteins - blood | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Proton Pump Inhibitors - blood | Blood Platelets - drug effects | Drug Resistance | Platelet Aggregation Inhibitors - adverse effects | Cell Adhesion Molecules - blood | Proton Pump Inhibitors - adverse effects | Down-Regulation | Cytochrome P-450 CYP2C19 - genetics | Biomarkers - blood | Pantoprazole - blood | Proton Pump Inhibitors - pharmacokinetics | Blood Platelets - metabolism | Pantoprazole - adverse effects | Cytochrome P-450 CYP2C19 - metabolism | Aged | Clopidogrel - adverse effects | Care and treatment | Usage | Critically ill | Clopidogrel | Cytochromes | Research | Health aspects | Index Medicus | Abridged Index Medicus | Clinical Trial
Journal Article
10/2011
Clopidogrel is prescribed in cardiac and extracardiac vascular diseases. It is generally well tolerated; however, few cases of taste disorders have been... 
clopidogrel | taste disorders | Ageusia
Web Resource
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2019, Volume 73, Issue 15, pp. S52 - S53
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2019, Volume 73, Issue 15, pp. S65 - S65
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 16, p. C71
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 16, p. C174
Journal Article
by Yang, Y.G and Zhang, M and Jiang, N and Song, L.X and Xu, X.T and Di, X.H and Xu, L and Xu, J and Zhao, G.T
Genetics and Molecular Research, ISSN 1676-5680, 12/2015, Volume 14, Issue 4, pp. 16736 - 16743
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2017, Volume 70, Issue 16, pp. C132 - C132
Objectives International multicenter clinical research (PLATO) confirmed that ticagrelor as a new type drug with stronger antithrombotic effect, significantly... 
Transluminal angioplasty | Angioplasty | Clopidogrel
Journal Article
Journal of Enam Medical College, ISSN 2227-6688, 02/2016, Volume 6, Issue 1, pp. 38 - 46
Antiplatelet agents are mainly used in the prevention and management of atherothrombotic complications. Dual antiplatelet therapy, combining aspirin and... 
some patients develop recurrent cardiovascular ischemic events especially stent thrombosis which is a serious clinical problem. Antiplatelet response to clopidogrel varies widely among patients based on ex vivo platelet function measurements. Clopidogrel is an effective inhibitor of platelet activation and aggregation due to its selective and irreversible blockade of the P2Y12 receptor. Patients who display little attenuation of platelet reactivity with clopidogrel therapy are labeled as low or nonresponders or clopidogrel resistant. The mechanism of clopidogrel resistance remains incompletely defined but there are certain clinical | India and Visiting Professor | is the standard care for patients having acute coronary syndromes or undergoing percutaneous coronary intervention according to the current ACC/AHA and ESC guidelines. But in spite of administration of dual antiplatelet therapy | No 1 > Neki Clopidogrel Resistance: Current Issues NS Neki Abstract Antiplatelet agents are mainly used in the prevention and management of atherothrombotic complications. Dual antiplatelet therapy | Department of Medicine | Amritsar | combining aspirin and clopidogrel | University of Minnitoba | Institute of Cardiovascular Sciences | cellular and genetic factors including polymorphisms responsible for therapeutic failure. Currently there is no standardized or widely accepted definition of clopidogrel resistance. The future may soon be realised in the routine measurement of platelet activity in the same way that blood pressure | Winnipeg | thus improving the care for millions of people. This review focuses on the methods used to identify patients with clopidogrel resistance | the underlying mechanisms | Government Medical College | Canada India Article Tools Print this article Indexing metadata How to cite item Finding References Email this article (Login required) Email the author (Login required) Information For Readers For Authors Home > Journal of Enam Medical College > Vol 6 | cholesterol and blood sugar are followed to help guide the therapy | Acute coronary syndrome; Percutaneous coronary intervention; Clopidogrel; Platelet aggregation | metabolism | and increase worldwide knowledge of indigenous scholarship. Read more. Browse By Issue By Author By Title Other Journals Login Username Password Remember me Journal Content Search Search Scope Browse By Issue By Author By Title Other Journals Subjects About The Author NS Neki Professor | Part of the JOL Project Supported by INASP Bangladesh Journals OnLine (BanglaJOL) is a service to provide access to Bangladesh published research
Journal Article
World journal of urology, ISSN 0724-4983, 02/2019, pp. 1 - 2
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 11/2012, Volume 27, Issue 11, pp. 2373 - 2386
Journal Article
European Heart Journal, ISSN 0195-668X, 8/2009, Volume 30, Issue 16, pp. 1964 - 1977
Currently, clopidogrel is recommended for treatment of patients with acute coronary syndrome and/or percutaneous coronary intervention. However, the delayed... 
Prasugrel | Clopidogrel | Thienopyridine | Cangrelor | Ticagrelor | Purinoceptor P2Y
Journal Article
AMERICAN JOURNAL OF THERAPEUTICS, ISSN 1075-2765, 05/2019, Volume 26, Issue 3, pp. E425 - E426
Journal Article
Chemical and Pharmaceutical Bulletin, ISSN 0009-2363, 2018, Volume 66, Issue 12, pp. 1165 - 1173
Clopidogrel bisulphate (CB) is a first line antiplatelet drug for treatment of myocardial infarction and stroke. Yet, its efficacy is limited by its poor... 
factorial design | cubosome | nanoparticle | bleeding time | clopidogrel bisulphate | buffer transition release study | Clopidogrel bisulphate | Bleeding time | Buffer transition release study | Factorial design | Nanoparticle | Cubosome | CHEMISTRY, MEDICINAL | SOLID DISPERSION | MONOOLEIN | AMPHOTERICIN-B | FORMULATION | CHEMISTRY, MULTIDISCIPLINARY | BIOAVAILABILITY | ANTIPLATELET | NANOPARTICLES | IN-VITRO | CUBIC PHASE | PHARMACOLOGY & PHARMACY | OPTIMIZATION | Clopidogrel - metabolism | Rabbits | Intestinal Mucosa - metabolism | Nanoparticles - chemistry | Administration, Oral | Absorption, Physiological | Intestines - chemistry | Solubility | Clopidogrel - administration & dosage | Clopidogrel - pharmacokinetics | Drug Delivery Systems | Particle Size | Animals | Nanoparticles - metabolism | Surface Properties | Anthelmintics - metabolism | Drug Liberation | Nanoparticles - administration & dosage | Anthelmintics - pharmacokinetics | Anthelmintics - administration & dosage | Hydrogen-Ion Concentration | Myocardial infarction | Cerebral infarction | Drug delivery systems | Stroke | Alcohol | Gastrointestinal tract | Drug delivery | pH effects | Bleeding | Nanoparticles | Entrapment | Absorption | Transmission electron microscopy | Intestine | Morphology | Gastrointestinal system | Genetically modified organisms | Clopidogrel | Polyvinyl alcohol | Buffers | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.